N Boyer

Author PubWeight™ 65.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy. Ann Intern Med 1997 3.49
2 Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 1995 2.54
3 Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 1991 2.38
4 Fatal exacerbation of chronic hepatitis B induced by recombinant alpha-interferon. Lancet 1991 2.14
5 Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C. Gut 2007 1.98
6 The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001 1.87
7 Second generation (RIBA) test in diagnosis of chronic hepatitis C. Lancet 1991 1.84
8 A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C. Hepatology 2000 1.67
9 Long term clinical outcome of chronic hepatitis C patients with sustained virological response to interferon monotherapy. Gut 2004 1.65
10 Cryoglobulinemia with vasculitis associated with hepatitis C virus infection. Gastroenterology 1993 1.64
11 Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4. Gut 2009 1.56
12 Hepatitis after intravenous buprenorphine misuse in heroin addicts. J Hepatol 2001 1.51
13 Influence of hepatitis G virus infection on the severity of liver disease and response to interferon-alpha in patients with chronic hepatitis C. Ann Intern Med 1997 1.44
14 Is the response to recombinant alpha interferon related to the presence of antibodies to hepatitis C virus in patients with chronic non-A, non-B hepatitis? J Hepatol 1990 1.43
15 Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol 2000 1.15
16 Isolation, sequencing and analysis of the expression of Bryonia calmodulin after mechanical perturbation. Plant Mol Biol 1993 1.13
17 Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut 2003 1.11
18 Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA. Hepatology 2001 1.05
19 Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C. Clin Biochem 2001 1.03
20 Demonstration of hepatitis B virus DNA by polymerase chain reaction in the serum and the liver after spontaneous or therapeutically induced HBeAg to anti-HBe or HBsAg to anti-HBs seroconversion in patients with chronic hepatitis B. Hepatology 1992 1.03
21 Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 1997 1.00
22 Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. J Hepatol 1998 1.00
23 Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. Clin Biochem 1999 0.98
24 Treatment of chronic hepatitis B. J Viral Hepat 2005 0.97
25 Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy. Gut 2003 0.93
26 Molecular cloning and characterization of tomato cDNAs encoding glutathione peroxidase-like proteins. Eur J Biochem 1998 0.92
27 Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment. J Hepatol 2001 0.91
28 Morphological responses and molecular modifications in tomato plants after mechanical stimulation. Plant Cell Physiol 1997 0.91
29 Hypocotyl Growth and Peroxidases of Bidens pilosus: EFFECT OF COTYLEDONARY PRICKINGS AND LITHIUM PRETREATMENT. Plant Physiol 1981 0.88
30 Long-term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferon. Liver 1994 0.87
31 Hypervariable region 1 quasispecies in hepatitis C virus genotypes 1b and 3 infected patients with normal and abnormal alanine aminotransferase levels. J Viral Hepat 2002 0.86
32 Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins. Clin Exp Immunol 2006 0.86
33 [Treatment of chronic hepatitis B]. Gastroenterol Clin Biol 2008 0.85
34 [Hepatic brucelloma: 2 cases and a review of the literature]. Gastroenterol Clin Biol 1999 0.84
35 Effects of a mechanical stimulation of localization of annexin-like proteins in Bryonia dioica internodes. Plant Physiol 1997 0.83
36 A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C. Liver 2000 0.83
37 Safety and efficacy of peginterferon plus ribavirin in patients with chronic hepatitis C and bridging fibrosis or cirrhosis. J Viral Hepat 2005 0.83
38 Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C. Gastroenterology 1995 0.83
39 Specific Inhibition of Lignification in Bryonia dioica: Effects on Thigmomorphogenesis. Plant Physiol 1987 0.82
40 [Preliminary evaluation of morbidity due to S. haematobium and S. mansoni in the area of the future Adjarala Dam in Benin]. Sante 2001 0.82
41 Treatment of hepatitis C patients with normal aminotransferases levels. Clin Liver Dis 1999 0.81
42 Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine. Gut 1993 0.80
43 Cytological indication of the involvement of calcium and calcium-related proteins in the early responses of Bryonia dioica to mechanical stimulus. Protoplasma 1993 0.79
44 Natural history of hepatitis B. Minerva Gastroenterol Dietol 2005 0.79
45 IFNL3 (IL28B) polymorphism does not predict long-term response to interferon therapy in HBeAg-positive chronic hepatitis B patients. J Viral Hepat 2013 0.79
46 Persistence of hepatitis B virus DNA demonstrated by polymerase chain reaction in serum and liver after loss of HBsAg induced by antiviral therapy. Ann Intern Med 1990 0.79
47 Accurate model predicting sustained response at week 4 of therapy with pegylated interferon with ribavirin in patients with chronic hepatitis C. J Viral Hepat 2006 0.79
48 Changes in liver fibrosis at the end of alpha interferon therapy and 6 to 18 months later in patients with chronic hepatitis C: quantitative assessment by a morphometric method. J Hepatol 1998 0.78
49 Non-insulin-dependent diabetes mellitus developing during interferon-alpha therapy for chronic hepatitis C. Ann Intern Med 1996 0.78
50 Management of chronic hepatitis C. Minerva Gastroenterol Dietol 2007 0.78
51 Recombinant human gamma-interferon in patients with chronic active hepatitis B: pharmacokinetics, tolerance and biological effects. Hepatology 1990 0.78
52 [Factors of response to treatment with interferon-alpha in patients with chronic hepatitis C. Therapeutic perspectives]. Gastroenterol Clin Biol 1995 0.78
53 Sequential therapy with adefovir dipivoxil and pegylated interferon alfa-2a for HBeAg-negative patients. J Viral Hepat 2010 0.76
54 Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B. Hepatology 1995 0.76
55 Hepatitis B virus precore mutations and HBeAg negative reactivation of chronic hepatitis B after interferon therapy. Liver 1995 0.76
56 Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patients. Hepatology 2000 0.76
57 Re-treatment with interferon alfa of patients with chronic hepatitis C. Hepatology 1998 0.76
58 An acute care geriatric unit. Nurs Manage 1986 0.75
59 Adenine arabinoside 5'-monophosphate in patients with chronic hepatitis B: comparison of the efficacy in patients with high and low viral replication. Gut 1995 0.75
60 Retreatment with interferon-alpha of chronic hepatitis C virus infection. Lancet 1994 0.75
61 [Treatment of hepatitis B]. Rev Med Interne 2002 0.75
62 Changes in plasma membrane fluidity of Bryonia dioica internodes during thigmomorphogenesis. Biochim Biophys Acta 1995 0.75
63 Tracking productivity: an easy, quick and useful way. Nurs Manage 1986 0.75
64 Interferon-alpha therapy for chronic hepatitis C in special patient populations. Dig Dis Sci 1996 0.75
65 Absence of effect of zidovudine on replication of hepatitis B virus in patients with chronic HIV and HBV infection. N Engl J Med 1989 0.75
66 Medical therapy of patients affected by HBeAg-negative chronic hepatitis B. Minerva Gastroenterol Dietol 2006 0.75
67 [Genetic variability of the hepatitis C virus: clinical implications]. Gastroenterol Clin Biol 2000 0.75
68 Treatment of chronic hepatitis c. Minerva Gastroenterol Dietol 2004 0.75
69 Acetylcholinesterase activity changes in medial vestibular complex after hemilabyrinthectomy in the rat. J Vestib Res 1996 0.75
70 Tolerability of treatments for viral hepatitis. Drug Saf 2001 0.75
71 Retreatment with recombinant interferon-alpha in patients with chronic hepatitis C. J Infect Dis 1993 0.75
72 Sequential rooting media and rooting capacity of Sequoiadendron giganteum in vitro. Peroxidase activity as a marker. Plant Cell Rep 1987 0.75